AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33257495 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Using Prolonged Exposure - Adolescent (COPE-A)
Number of subjects: 100
Study 33257495 — intervention group
Group type: COMPARATOR
Intervention: Person-Centred Therapy (PCT)
Number of subjects: 100
Study 35123427 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS combined with CBT
Number of subjects: 132
Study 35123427 — intervention group
Group type: COMPARATOR
Intervention: Next pharmacological step (switch to tricyclic antidepressant or augmentation with lithium or second-generation antipsychotic) combined with CBT
Number of subjects: 132
Study 33607029 — intervention group
Group type: EXPERIMENTAL
Intervention: Household finished flooring
Number of subjects: 7795
Study 32481305 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu Qiangxin Pills (SFQX)
Number of subjects: 352
Study 32481305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study 35546412 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized app with individual feedback regarding self-reported medication intake for 12 months
Number of subjects: 960
Study 35546412 — intervention group
Group type: COMPARATOR
Intervention: Customized app without individual feedback regarding self-reported medication intake for 12 months
Number of subjects: 960
Study 32804212 — intervention group
Group type: EXPERIMENTAL
Intervention: MATCH
Number of subjects: 206
Study 32804212 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 206
Study 33026243 — intervention group
Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg, 15 mg pooled)
Number of subjects: 8246
Study 33397319 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication-related early stimulation behaviors (ESB)
Number of subjects: 374
Study 33397319 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical intimate partner violence (IPV)
Number of subjects: 374
Study 32577113 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated daily text-messages regarding pain, opioid utilization, and a daily CBT intervention
Number of subjects: 14
Study 32577113 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative communication limited to a two-week postoperative follow-up visit
Number of subjects: 14
Study 32577113 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated mobile phone messaging
Number of subjects: 14
Study 32577113 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient reported opioid utilization via software messaging system
Number of subjects: 14
Study 35202470 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbance (slight, moderate, or great)
Number of subjects: 810
Study 35202470 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbance levels measured at 6 months
Number of subjects: 810
Study 35202470 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep disturbances during weight loss from baseline to 6 months
Number of subjects: 810
Study 35202470 — intervention group
Group type: EXPERIMENTAL
Intervention: Food cravings and eating behaviors measured at 6 months
Number of subjects: 810
Study 35718313 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy comfort food (e.g., grapes)
Number of subjects: 129
Study 35718313 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy comfort food (e.g., chips)
Number of subjects: 129
Study 35718313 — intervention group
Group type: COMPARATOR
Intervention: No food
Number of subjects: 129
Study 35718313 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy comfort food, unhealthy comfort food, and no food
Number of subjects: 129
Study 35718313 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (healthy, unhealthy, no food)
Number of subjects: 129
Study 33276744 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (45 min once a week for 12 weeks)
Number of subjects: 80
Study 33276744 — intervention group
Group type: COMPARATOR
Intervention: Non-musical intervention (45 min once a week for 12 weeks)
Number of subjects: 80
Study 34035312 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 mcg via ELLIPTA
Number of subjects: 800
Study 34035312 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (TIO) 18 mcg via HandiHaler
Number of subjects: 800
Study 32039962 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-driven quality-improvement program including reminder calls, parent education, proactive appointment scheduling, and social media reminders
Number of subjects: 0
Study 34233928 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study 34233928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study 33212947 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose, Omega-3 fatty acids, and Vitamin E
Number of subjects: 0
Study 32492727 — intervention group
Group type: EXPERIMENTAL
Intervention: Student instructors
Number of subjects: 100
Study 32492727 — intervention group
Group type: COMPARATOR
Intervention: Clinical staff physicians
Number of subjects: 100
Study 32492727 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents
Number of subjects: 100
Study 32492727 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendings
Number of subjects: 100
Study 34039302 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow blue protocol (BP) stimulating ipRGCs
Number of subjects: 62
Study 34039302 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast yellow protocol (YP) stimulating luminance channels
Number of subjects: 62
Study 34039302 — intervention group
Group type: COMPARATOR
Intervention: Migraine occurring up to 2 weeks before testing
Number of subjects: 62
Study 34039302 — intervention group
Group type: COMPARATOR
Intervention: Triptan use
Number of subjects: 62
Study 35124187 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigators' practices following trial discontinuation
Number of subjects: 49
Study 35124187 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigators' sense of failure and associated negative emotions
Number of subjects: 49
Study 35124187 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic approach to notifying stakeholders and publishing results
Number of subjects: 49
Study 35124187 — intervention group
Group type: EXPERIMENTAL
Intervention: Support programs for investigators
Number of subjects: 49
Study 34060027 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NACT) followed by cold knife conization (CKC)
Number of subjects: 13
Study 33893516 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized lingual brackets
Number of subjects: 20
Study 33893516 — intervention group
Group type: COMPARATOR
Intervention: Conventional labial brackets
Number of subjects: 20
Study 35745176 — intervention group
Group type: EXPERIMENTAL
Intervention: Test potato cv. SQ containing 45 mg anthocyanin
Number of subjects: 15
Study 35745176 — intervention group
Group type: COMPARATOR
Intervention: Placebo potatoes cv. 'Haruka'
Number of subjects: 15
Study 34116176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.4 mg/kg
Number of subjects: 94
Study 34116176 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol 0.5 mg/kg
Number of subjects: 94
Study 34116176 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2.0 mg/kg
Number of subjects: 94
Study 32272478 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Conservation Techniques (ECTs) taught over a 2-week period
Number of subjects: 32
Study 36453709 — intervention group
Group type: EXPERIMENTAL
Intervention: Clazakizumab (anti-IL-6)
Number of subjects: 0
Study 36453709 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (anti-IL-6R)
Number of subjects: 0
Study 36453709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34619937 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based comprehensive intervention (Group A)
Number of subjects: 15226
Study 34619937 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of community-based comprehensive intervention and internet-based intervention (Group B)
Number of subjects: 15226
Study 32650346 — intervention group
Group type: EXPERIMENTAL
Intervention: CH-EUS-FNA
Number of subjects: 148
Study 32650346 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA
Number of subjects: 148
Study 32650346 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined EUS-FNA and CH-EUS-FNA
Number of subjects: 148
Study 32650346 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA and CH-EUS-FNA
Number of subjects: 148
Study 35321743 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Exercise (HIIT)
Number of subjects: 0
Study 35321743 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Exercise (MICT)
Number of subjects: 0
Study 35321743 — intervention group
Group type: COMPARATOR
Intervention: Untrained Control (UC)
Number of subjects: 0
Study 34048716 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks of amoxicillin‐clavulanate (25‐35 mg/kg twice daily oral suspension)
Number of subjects: 106
Study 34048716 — intervention group
Group type: COMPARATOR
Intervention: 2 weeks of amoxicillin‐clavulanate followed by 2 weeks of placebo
Number of subjects: 106
Study 34048716 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks of amoxicillin‐clavulanate
Number of subjects: 106
Study 35460434 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks’ daily remote ischaemic conditioning (CRIC)
Number of subjects: 73
Study 35460434 — intervention group
Group type: COMPARATOR
Intervention: Sham conditioning (Control)
Number of subjects: 73
Study 33927115 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein protein hydrolysate
Number of subjects: 24
Study 33927115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 36331944 — intervention group
Group type: EXPERIMENTAL
Intervention: Power motivation arousal (20 min of The Experiment)
Number of subjects: 140
Study 36331944 — intervention group
Group type: COMPARATOR
Intervention: Control condition (20 min of Beautiful China documentary)
Number of subjects: 140
Study 34042999 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation
Number of subjects: 0
Study 34042999 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 0
Study 32951301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 171
Study 32951301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 35083757 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based remote follow-up management
Number of subjects: 150
Study 35083757 — intervention group
Group type: COMPARATOR
Intervention: Traditional outpatient follow-up management
Number of subjects: 150
Study 36167307 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (starting at day +3 post Auto-HSCT)
Number of subjects: 140
Study 36167307 — intervention group
Group type: COMPARATOR
Intervention: No G-CSF (G-CSF withheld after Auto-HSCT)
Number of subjects: 140
Study 36167307 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 140
Study 36167307 — intervention group
Group type: COMPARATOR
Intervention: No G-CSF
Number of subjects: 140
Study 36167307 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF and No G-CSF
Number of subjects: 140
Study 33726828 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose theophylline (200 mg ER, Unicontin-E) once daily for 52 weeks
Number of subjects: 110
Study 33726828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 33726828 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose theophylline (200 mg ER, Unicontin-E)
Number of subjects: 110
Study 32969781 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (Oxy)
Number of subjects: 10
Study 32969781 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 10
Study 36857968 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg/d) and Quercetin (1250 mg/d), three consecutive days per week for three weeks
Number of subjects: 12
Study 36857968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33901300 — intervention group
Group type: EXPERIMENTAL
Intervention: RMST-based approach
Number of subjects: 200
Study 33901300 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 200
Study 36198573 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tidal volume ventilation facilitated by veno‐venous extracorporeal carbon dioxide removal (vv‐ECCO2R)
Number of subjects: 412
Study 36198573 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 412
Study 36198573 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tidal volume ventilation facilitated by vv‐ECCO2R
Number of subjects: 412
Study 34213869 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater Occipital Nerve Block (GONB)
Number of subjects: 93
Study 34213869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenopalatine Ganglion Block (SPGB)
Number of subjects: 93
Study 32076549 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA/low-GI diet
Number of subjects: 533
Study 32076549 — intervention group
Group type: COMPARATOR
Intervention: High-SFA/high-GI diet
Number of subjects: 533
Study 32076549 — intervention group
Group type: EXPERIMENTAL
Intervention: Total NEFA levels
Number of subjects: 533
Study 33516681 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based exercise program (3 times per week for 20 minutes over 24 weeks)
Number of subjects: 70
Study 34332699 — intervention group
Group type: EXPERIMENTAL
Intervention: InterVA-4
Number of subjects: 69330
Study 34332699 — intervention group
Group type: EXPERIMENTAL
Intervention: InterVA-5
Number of subjects: 69330
Study 34332699 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician review
Number of subjects: 69330
Study 34332699 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician review (India only)
Number of subjects: 69330
Study 34332699 — intervention group
Group type: EXPERIMENTAL
Intervention: InterVA-4 vs InterVA-5
Number of subjects: 69330
Study 34709013 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block with 20 mL of ropivacaine 0.5%
Number of subjects: 183
Study 34709013 — intervention group
Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 183
Study 33217361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (28-day interval)
Number of subjects: 423
Study 33217361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (56-day interval)
Number of subjects: 423
Study 33217361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (84-day interval)
Number of subjects: 423
Study 33217361 — intervention group
Group type: COMPARATOR
Intervention: Placebo (28-day interval)
Number of subjects: 423
Study 33217361 — intervention group
Group type: COMPARATOR
Intervention: Placebo (56-day interval)
Number of subjects: 423
Study 33217361 — intervention group
Group type: COMPARATOR
Intervention: Placebo (84-day interval)
Number of subjects: 423
Study 33217361 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (overall)
Number of subjects: 423
Study 32730310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery monetary incentive package
Number of subjects: 36
Study 32730310 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed monetary incentive package
Number of subjects: 36
Study 32730310 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (delayed monetary incentive) control group
Number of subjects: 36
Study 32730310 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study 35821429 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation of unstable ankle fractures
Number of subjects: 148
Study 33387970 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress exposure (Trier Social Stress Test)
Number of subjects: 179
Study 33387970 — intervention group
Group type: COMPARATOR
Intervention: Non-stress control condition (resting period)
Number of subjects: 179
Study 33387970 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary alpha-amylase (sAA) levels in Study 1
Number of subjects: 179
Study 33387970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol levels in females in Study 2
Number of subjects: 179
Study 33387970 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower anticipatory subjective stress responses
Number of subjects: 179
Study 33387970 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical moral decision-making
Number of subjects: 179
Study 32734847 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with 20 μl of spore suspension (10^4 conidia per ml) from a 21-day-old PDA culture.
Number of subjects: 12
Study 32734847 — intervention group
Group type: COMPARATOR
Intervention: Mock-inoculated controls with sterile water.
Number of subjects: 12
Study 35493813 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (10 Hz stimulation over the left dorsolateral prefrontal cortex)
Number of subjects: 0
Study 35493813 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham stimulation)
Number of subjects: 0
Study 35386029 — intervention group
Group type: EXPERIMENTAL
Intervention: Flip-chart assisted education regarding essential newborn care (ENC)
Number of subjects: 120
Study 35386029 — intervention group
Group type: COMPARATOR
Intervention: Verbal advice on ENC from postnatal ward nurses
Number of subjects: 120
Study 33487303 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium treatment
Number of subjects: 240
Study 33487303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 32045825 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First (HF) model
Number of subjects: 5631
Study 36257876 — intervention group
Group type: EXPERIMENTAL
Intervention: Bursitis label plus guideline‐based advice
Number of subjects: 2024
Study 36257876 — intervention group
Group type: EXPERIMENTAL
Intervention: Bursitis label plus treatment recommendation
Number of subjects: 2024
Study 36257876 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotator cuff tear label plus guideline‐based advice
Number of subjects: 2024
Study 36257876 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotator cuff tear label plus treatment recommendation
Number of subjects: 2024
Study 36257876 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline‐based advice
Number of subjects: 2024
Study 36257876 — intervention group
Group type: COMPARATOR
Intervention: Treatment recommendation
Number of subjects: 2024
Study 33441218 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy‐balanced diet during SUSOPS (BAL)
Number of subjects: 10
Study 33441218 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy‐deficient controlled diet during SUSOPS (DEF)
Number of subjects: 10
Study 33441218 — intervention group
Group type: COMPARATOR
Intervention: Energy‐balanced diet while sedentary (REST)
Number of subjects: 10
Study 35549747 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralaterally controlled functional electrical stimulation (CCFES)
Number of subjects: 129
Study 35549747 — intervention group
Group type: COMPARATOR
Intervention: Cyclic neuromuscular electrical stimulation (cNMES)
Number of subjects: 129
Study 35549747 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented training (TOT)
Number of subjects: 129
Study 33444369 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage Body Fat (PBF)
Number of subjects: 489
Study 33444369 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 489
Study 33444369 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat Mass Index (FMI)
Number of subjects: 489
Study 32674613 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied for 20 minutes.
Number of subjects: 30
Study 32674613 — intervention group
Group type: COMPARATOR
Intervention: Sham group (stimulating device set but not turned on).
Number of subjects: 30
Study 36137355 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation treadmill with proprioception ability measured by AUC scores
Number of subjects: 60
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 5–6 students
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Low educational level of father
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Low educational level of mother
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Joblessness of father
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment of mother
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Large family size
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of shared articles
Number of subjects: 480
Study 34034686 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of bathroom in the house
Number of subjects: 480
Study 32878613 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide 240 mg orally once-daily
Number of subjects: 68
Study 34409858 — intervention group
Group type: EXPERIMENTAL
Intervention: Balstilimab alone
Number of subjects: 0
Study 34409858 — intervention group
Group type: EXPERIMENTAL
Intervention: Balstilimab in combination with zalifrelimab
Number of subjects: 0
Study 33232912 — intervention group
Group type: EXPERIMENTAL
Intervention: Krill oil supplementation (400 mg EPA and DHA for 3 months, then 800 mg EPA and DHA for 9 months)
Number of subjects: 0
Study 33232912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36349244 — intervention group
Group type: EXPERIMENTAL
Intervention: E-OJ-01 (400 mg/day for 8 weeks)
Number of subjects: 72
Study 36349244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 32991450 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir
Number of subjects: 276
Study 32991450 — intervention group
Group type: COMPARATOR
Intervention: lamivudine
Number of subjects: 276
Study 32903142 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day administration of pegfilgrastim
Number of subjects: 0
Study 33629809 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS combined with ROSE
Number of subjects: 152